PN-881: A Next-Generation Oral IL-17 Antagonist Redefining Peptide Immunotherapy

Name: PN-881: A Next-Generation Oral IL-17 Antagonist Redefining Peptide Immunotherapy
Start: 2027-04-28T14:30
End: 2027-04-28T15:00
Location: Hynes Convention Center

Tides 2027 · 28 April 2027 · 14:30–15:00

PN-881: A Next-Generation Oral IL-17 Antagonist Redefining Peptide Immunotherapy was a session at Tides 2027 on 28 April 2027 in Boston.